Sino-Argi Leading Biosciences (603970) - Total Assets
Based on the latest financial reports, Sino-Argi Leading Biosciences (603970) holds total assets worth CN¥6.57 Billion CNY (≈ $960.83 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Sino-Argi Leading Biosciences - Total Assets Trend (2012–2025)
This chart illustrates how Sino-Argi Leading Biosciences's total assets have evolved over time, based on quarterly financial data. Also see Sino-Argi Leading Biosciences (603970) market capitalisation for the company's overall valuation and market capitalisation.
Sino-Argi Leading Biosciences - Asset Composition Analysis
Current Asset Composition (December 2025)
Sino-Argi Leading Biosciences's total assets of CN¥6.57 Billion consist of 94.6% current assets and 5.4% non-current assets. Review 603970 total debt and obligations to assess the company's total debt and financial obligations.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 5.1% |
| Accounts Receivable | CN¥1.45 Billion | 29.6% |
| Inventory | CN¥1.47 Billion | 29.9% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥3.08 Million | 0.1% |
| Goodwill | CN¥0.00 | 0.0% |
Asset Composition Trend (2012–2025)
This chart illustrates how Sino-Argi Leading Biosciences's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See current stock price of Sino-Argi Leading Biosciences for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Sino-Argi Leading Biosciences's current assets represent 94.6% of total assets in 2025, a decrease from 98.1% in 2012.
- Cash Position: Cash and equivalents constituted 5.1% of total assets in 2025, down from 6.1% in 2012.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2012.
- Asset Diversification: The largest asset category is inventory at 29.9% of total assets.
Sino-Argi Leading Biosciences Competitors by Total Assets
Key competitors of Sino-Argi Leading Biosciences based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Qinghai Salt Lake Industry Co.Ltd
SHE:000792
|
China | CN¥61.57 Billion |
|
Shaanxi Meibang Pharmaceutical Group Co Ltd
SHG:605033
|
China | CN¥1.91 Billion |
|
Boa Safra Sementes S.A
SA:SOJA3
|
Brazil | R$4.01 Billion |
|
Soquicom
SN:SOQUICOM
|
Chile | CL$133.30 Million |
|
Verde Agritech PLC
TO:NPK
|
Canada | CA$76.90 Million |
|
EMMERSON PLC O.N.
F:4UM
|
Germany | €1.69 Million |
|
Terragen Holdings Ltd
AU:TGH
|
Australia | AU$5.84 Million |
|
Neurizer Ltd
AU:NRZ
|
Australia | AU$132.63 Million |
Sino-Argi Leading Biosciences - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.33 | 1.28 | 1.27 |
| Quick Ratio | 0.79 | 0.79 | 0.79 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥1.54 Billion | CN¥1.51 Billion | CN¥1.06 Billion |
Sino-Argi Leading Biosciences - Advanced Valuation Insights
This section examines the relationship between Sino-Argi Leading Biosciences's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.16 |
| Latest Market Cap to Assets Ratio | 0.09 |
| Asset Growth Rate (YoY) | -12.3% |
| Total Assets | CN¥4.91 Billion |
| Market Capitalization | $438.57 Million USD |
Valuation Analysis
Below Book Valuation: The market values Sino-Argi Leading Biosciences's assets below their book value (0.09x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Sino-Argi Leading Biosciences's assets decreased by 12.3% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Sino-Argi Leading Biosciences (2012–2025)
The table below shows the annual total assets of Sino-Argi Leading Biosciences from 2012 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥4.91 Billion ≈ $718.70 Million |
-12.33% |
| 2024-12-31 | CN¥5.60 Billion ≈ $819.79 Million |
-6.76% |
| 2023-12-31 | CN¥6.01 Billion ≈ $879.19 Million |
-3.78% |
| 2022-12-31 | CN¥6.24 Billion ≈ $913.70 Million |
+31.68% |
| 2021-12-31 | CN¥4.74 Billion ≈ $693.86 Million |
+17.84% |
| 2020-12-31 | CN¥4.02 Billion ≈ $588.84 Million |
+46.89% |
| 2019-12-31 | CN¥2.74 Billion ≈ $400.87 Million |
+5.98% |
| 2018-12-31 | CN¥2.58 Billion ≈ $378.25 Million |
-7.12% |
| 2017-12-31 | CN¥2.78 Billion ≈ $407.23 Million |
+7.80% |
| 2016-12-31 | CN¥2.58 Billion ≈ $377.75 Million |
+2.60% |
| 2015-12-31 | CN¥2.52 Billion ≈ $368.18 Million |
+28.42% |
| 2014-12-31 | CN¥1.96 Billion ≈ $286.69 Million |
+18.43% |
| 2013-12-31 | CN¥1.65 Billion ≈ $242.07 Million |
+34.16% |
| 2012-12-31 | CN¥1.23 Billion ≈ $180.44 Million |
-- |
About Sino-Argi Leading Biosciences
Sino-Agri Leading Biosciences Co.,Ltd engages in pesticide distribution in China and internationally. The company sells technical materials, formulations, and related products. It also provides plant protection technology services; and crop health solutions, including technical guidance, application demonstration, and processing and packaging of plant protection products. In addition, the company… Read more